Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 594,697
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $56,737,885
Total People Sold 5 5 6 7
Total Sell Transactions 11 15 24 53
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 1213
  Page 20 of 49  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-11-01 4 AS $33.26 $83,145 D/D (2,500) 40,104     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-11-01 4 OE $14.39 $35,975 D/D 2,500 42,604     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-11-01 4 AS $33.23 $8,641 D/D (260) 39,651     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2011-10-31 5 B $13.23 $2,658 D/D 201 46,679     -
   Mueller Brian VP, Corporate Controller   •       –      –    2011-10-31 5 B $13.23 $12,750 D/D 964 8,300     -
   Baffi Robert EVP, Technical Operations   •       –      –    2011-10-31 5 B $13.26 $4,416 D/D 333 83,493     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-10-31 4 A $13.23 $2,063 D/D 156 36,611     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-10-31 4 A $13.23 $3,016 D/D 228 40,104     -
   Davis George Eric SVP, General Counsel   •       –      –    2011-10-31 4 A $13.23 $3,439 D/D 260 39,911     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2011-10-28 4 AS $35.00 $590,625 D/D (16,875) 46,478     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2011-10-28 4 OE $14.39 $242,831 D/D 16,875 63,353     -
   Wood Mark VP, Human Resources   •       –      –    2011-10-24 4 AS $33.32 $61,750 D/D (1,853) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2011-10-24 4 OE $14.39 $32,884 D/D 1,853 22,487     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-10-10 4 AS $34.00 $624,886 D/D (18,379) 39,876     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-10-10 4 OE $17.54 $322,368 D/D 18,379 58,255     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-10-03 4 AS $31.00 $77,507 D/D (2,500) 36,455     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2011-10-03 4 OE $11.05 $27,625 D/D 2,500 38,955     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2011-09-28 4 AS $32.00 $32,000 D/D (1,000) 126,093     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-09-28 4 AS $32.00 $588,128 D/D (18,379) 39,876     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-09-28 4 OE $17.54 $322,368 D/D 18,379 58,255     -
   Wood Mark VP, Human Resources   •       –      –    2011-09-22 4 AS $29.92 $55,472 D/D (1,854) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2011-09-22 4 OE $14.39 $32,898 D/D 1,854 22,488     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-09-01 4 AS $29.41 $73,513 D/D (2,500) 39,876     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2011-09-01 4 OE $14.39 $35,975 D/D 2,500 42,376     -
   Wood Mark VP, Human Resources   •       –      –    2011-08-31 4 AS $30.00 $25,020 D/D (834) 20,634     -
  1213 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 20 of 49
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us